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The emergence of the novel human coronavirus (Severe 
acute respiratory syndrome coronavirus 2; abbreviated as: 
SARS-CoV-2) generally known as COVID-19 is a global 
health concern.1 On 11 February 2020, the World Health 
Organization (WHO) named the novel viral pneumonia as 
“Corona Virus Disease” (COVID-19). The International 
Committee on Taxonomy of Viruses (ICTV) suggested this 
novel coronavirus be named “SARS-CoV-2” due to the 
phylogenetic and taxonomic analysis of this virus.2 Thus, 
both terms are utilised interchangeably in the literature. 
 
Undoubtedly, COVID-19 will change the way we prac- 
tice dentistry with vast implications for Oral health-care 
workers (OHCW) and practice staff. Additionally, if rigo- 
rous safety protocols are not implemented based on a 
risk assessment outlined by the CDC, the dental practice 
can potentially become a nexus for disease transmission 
due to the high volume of aerosol production on a daily 
basis. Personal protective equipment (PPE), staff training 
and practice disinfection protocols have now especially 
become important in the light of the current pandemic. 
This is not a fight that one profession can fight alone, it 
requires joint efforts, it requires all stakeholders, it requi- 
res foresight and it requires us to put the health of the 
communities above all  else.
OHCW face an overall elevated risk of exposure to 
various infectious diseases.3 The dental setting and 
wide range of procedures expose the OHCW via nume- 
 
rous pathways to pathogenic micro-organisms (such as 
viruses and bacteria) that infect the oral cavity and res- 
piratory tract of  a patient.1
 • Refers to infections from infected person to a sus- 
ceptible individual through the transfer of virus-laden 
respiratory secretions. This transfer can be directly (via 
physical contact) or indirectly (via intermediate surfaces 
or objects).
 • Refers to infections transmitted by deposition of virus 
laden respiratory droplets expelled from an infected 
person onto mucosal surfaces (eyes, nose, mouth).
 • Refers to infection via inhalation of virus laden fine 
respiratory droplets (aerosols) through the air. These 
aerosols are generated either directly from fine res- 
piratory droplets expelled from infected person or when 
any aerosol generating procedure is performed on 
an infected person. Aerosols thus refer to particles in 
suspension.
Figure 1 demonstrates the potential routes of COVID-19 
transmission in the dental practice. OHCW can be ex- 
posed to COVID-19 via direct and indirect transmission 
pathways. Direct routes of transmission include exposure 
to droplets and aerosols generated during dental pro- 
cedures. Indirect routes of transmission include the 
contact of the OHCW to contaminated surfaces in the 
dental practice as well  as exposed auxiliary staff.
The classification COVID-19 as an infectious agent being 
“aerosol-transmissible” has significant implications for 
OHCW and the type of Personal Protective Equipment 
(PPE) that is required.5
 
Established routes of transmission of COVID-19 in 
humans includes direct transmission (through cough, 
sneeze, droplet inhalation) and contact transmission 
(contact via oral, nasal and eye mucous membranes).2 
Evidence suggests that even non-symptomatic indivi- 
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COVID-19: Focus on masks  
and respirators – Implications for oral  
health-care workers
duals can spread COVID-19 with high efficiency. Case 
studies from The Peoples Republic of China have also 
demonstrated that even after recovery from acute ill- 
ness patients continued to shed high amounts of the 
virus.3
Dental practices carry a very high risk of COVD-19 
transmission due to close proximity of the oral cavity 
and face-to-face communication with patients. The pro- 
cedures conducted in daily practice causes repeated 
exposure of the OHCW to aerosol, blood and saliva.2 
Studies utilizing viral culture methods have shown that 
Covid-19 is present in saliva samples.6 Currently, ocular 
symptoms are not commonly associated with COVID-19 
infection. However, analysis of conjunctival samples from 
confirmed cases of COVID-19, suggests that transmis- 
sion is not limited to the respiratory tract and that eye 
exposure may be an effective pathway for the virus to 
enter the body.2
The utilization of the correct PPE is not only limited to 
the dental practitioner. The entire dental team should be 
equipped and trained in the use of the correct PPE and 
disinfection protocols. A survey under dental assistants 
from the Limpopo province reported that a mere 76.3% 
wore masks during dental procedures.7
For the OHCW the mask will become an essential PPE 
item of practice as COVID-19 continues to spread. The 
World Health Organisation (WHO), currently recommends 
that individuals who show signs of respiratory symptoms 
(cough and difficulty breathing) with fever, should wear 
a mask and seek medical attention.8 
The world is contemplating as to whether all indivi- 
duals wearing masks in public would help to flatten the 
curve of the spread. This is a growing concern as many 
countries are reportedly running out of facemasks and 
respirators. 
Countries are adopting various strategies to drastically 
increase the production of this form of PPE. The question 
however remains: “Can a mask really protect you from 
catching the virus?” More importantly: “Are these masks 
protecting health care workers from contracting the 
dreaded COVID-19?” The answer to this question needs 
to contemplate the size of the COVID-19 virus and the 
level of determined filtration that masks and respirators 
currently offer.
It is important to note that not all masks and respirators 
products perform optimally in all clinical settings. Masks 
and respirators present only one component of PPE. 
OHCW should correctly select and apply masks and 
respirators in the clinical environment. This require an 
in-depth knowledge and understanding of droplet and 
aerosol transmission, to place the COVID-19 pandemic 
into perspective.
Dental literature has demonstrated that many dental pro- 
cedures produce aerosols and droplets that are con- 
taminated with pathogenic micro-organisms, such as a 
bacteria and viruses.9 
It is important to realise that all individuals are ex- 
posed to aerosols and droplet in daily life. Table 1 
provides insight to understanding the implications of 
particle size of an aerosol and droplet, since particle 
sizes have significant implications for disease trans- 
mission.4,5
Both droplets and aerosols are generated during cough- 
ing, sneezing, talking and even exhaling.4 Normal daily 
activities such as speaking and breathing have recorded 
predominant particle sizes of 1 μm, regardless of voice 
amplitude projected.12,13,14
The particles generated from coughing have a greater 
velocity and range between 0.57 to 0.89 μm (average 
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Figure 1. Adapted illustration of  transmission routes of COVID-19 in the dental  setting.3
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0.63 μm).15 Sneezing reportedly produces the largest 
droplet with an approximate particle size of 360.1 μm.16 
Studies have demonstrated that 1µm particles have suf- 
ficient volume to transmit diseases from one person to 
another. Despite their small size, however, these micron-
scale particles are sufficiently large enough to carry a 
variety of respiratory pathogens such the measles virus 
(0.05-0.5 µm)17, influenza virus (0.1-1 μm)18 and Myco- 
bacterium tuberculosis (1-3 μm).19
Recent work by Yan et al. has confirmed that significant 
amounts of influenza viral RNA are present in small 
particles (<5 μm) emitted by influenza-infected individuals 
during natural breathing, even without the infected in- 
dividual coughing or sneezing.20 
The risk of transmission with COVID-19 becomes ap- 
parent when the particle size ranging between 0.06 
and 0.14 µm is considered.21 Thus, COVID-19 can be 
considered as a ‘small particle’ microbe with a high 
potential risk of  airborne transmission.
In the dental practice, aerosols are produced by equip- 
ment such as ultrasonic scalers and fast hand pieces. 
Aerosolised water from dental equipment can range from 
aerosol to splatter (0.001 µm to 50 µm). Aerosols with 
particles greater than 100 µm, settle quickly to the floor 
and other surfaces.22 Aerosols become suspended in the 
air when the particle size is smaller than 50 µm.23
Dental lasers are included as an aerosol producing pro- 
cedures due to the generation of the lasers plume. For 
lasers high-efficiency particulate filtration respirator to the 
efficiency of 99.75% at 0.1μm have been suggested.24 
For dental lasers this would therefore be a respirator 
with a rating of N99, N100 or  FFP3.
A Study evaluating the air quality in a dental setting 
with dental procedures such as extractions, air turbine 
with water spray and ultrasonic procedures, found that 
the micro-organism level in the dental surgery generally 
took 10-30 minutes to return to normal. This study also 
calculated that the practitioner and assistant was ex- 
posed to between 0.014 µl to 0.12 µl aerosolised saliva 
during a 15 minute peak exposure  period.
Based on the results obtained, the study calculated that 
if a patient with Mycobacterium tuberculosis (M. tuber- 
culosis) was treated, the practitioner could potentially 
have inhaled between 0.98 to 8.40 colony forming units 
(cfu) of M. tuberculosis, resulting in infection. Airborne 
M. tuberculosis is the main route of transmission gene- 
rated by coughs and sneezes with droplet nuclei 1-5 µm 
in size.25
Studies have shown that COVID-19 become airborne 
through aerosols and droplets, generated during medical 
and dental procedures.26 Dental practice generated drop- 
lets and aerosols from infected patients are likely to 
contaminate the whole surfaces in a dental practice.2 
Studies investigating generated 5µm COVID-19 parti- 
cles, reported that they remained viable for the dura- 
tion of the 3 hour in vitro experiment. Further to this, 
COVID-19 was demonstrated to be the most stable 
when it remained on plastic and stainless steel sur- 
faces, compared to copper and cardboard. 
Although the COVID-19 virus reduced in virility over 
time, viable particles were present up to 72 hours 
after application to these surfaces. The half-live of aero- 
solised Covid-19 in the air had a virility of about 1.1 hours.26 
The problem that therefore exists with COVID-19, is the 
ability to settle on surfaces within the practice, where it can 
survive for extended periods of time.
In 1963 Miller et al. demonstrated that polishing cups, 
air turbines with water spray and polishing restorations 
with a bristle brush generated particles with various 
levels of  microbial  contamination.10 
Besides the guidelines that the Centres for Disease 
Control and WHO will advise in due time, OHCW can 
start to reduce the microbial load in the oral cavities 
of patients with pre-procedural mouth rinses27, tooth 
brushing before the visit28 and high volume evacuation29 
next to the aerosol generating equipment.30 
According to “Guideline for Diagnosis and Treatment of 
Novel Coronavirus Pneumonia” (National Health Com- 
mission) chlorhexidine as a pre-procedural mouth rinse 
may not be effective to kill COVID-19. COVID-19 
is vulnerable to oxidation, thus pre-procedural mouth 
rinses containing oxidative agents such as 1% hydro- 
gen peroxide or 0,2% povidone are recommended to 
reduce the salivary load of microbes (including COVID-19 
carriage).2
Additionally, studies have also concluded that the use 
of rubber dams significantly reduce the contamination 
to the OHCW and the surrounding dental environment.31 
Lastly disposable protective clothing and a protective 
face shield (as recommended by the CDC) additionally 
aid in the protection from splatter droplets, since droplets 
escape the high volume evacuation due to the air stream 
flowing from the dental equipment.32
AEROSOLS IN DENTISTRY
REDUCTION OF AEROSOL
Table 1. Particle sizes and implications of transmission.
Particle size Implications for transmission
 < 5-10µm
‘small particles’
This is aerosol and can be smaller than 5 µm as well.
Aerodynamic diameter that follow airflow streamlines.
Mainly short range transmission4 and long range if 
strong air currents present.
Readily penetrates the airways all the way down to 
the alveolar space (causing lower respiratory tract in-
fections LRT).4
High risk for airborne transmission.10,11
> 20µm
‘large particles’
This splatter than can travel 15-120 cm from  
the patient.
Follow a more ballistic trajectory (i.e. falling mostly 
under the influence of gravity – where the droplets are 
too large to follow inhalation airflow streamlines.
Most likely impact respiratory epithelial mucosa sur-
faces or trapped by cilia before reaching lower respi-
ratory tract (LRT).
Associated with upper respiratory tract (URT)  
infections.10,11
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There are various masks and respirators available in the 
medical profession. Facial filtering protective equipment 
can be categorised into two broad categories, namely 
masks and respirators. They are fundamentally different in 
their intended use and the level of protection they provide.
An ear loop mask primarily assists in preventing transmis-
sion of biological particles (e.g. bacteria and viruses) 
expelled by the wearer. Many ear loop masks offer some 
level of fluid resistance. The particle filter capabilities vary. 
High quality earloop masks are expected to possess a 
mean particle filter size of 4µm.
Surgical masks (predominantly worn in theatre) have 
the primary purpose of preventing biological particles in 
droplet form infecting the health care practitioner. The 
expelled droplets and aerosol generated by the prac- 
titioner (by breathing, talking, sneezing etc.) is filtered 
to prevent contamination of the surgical environment.34 
Surgical masks are also designed to be fluid-resistant to 
splash and splatter of blood and other bodily fluids dur- 
ing a procedure. A high quality surgical mask can filter 
mean particle sizes  of 2.7µm.
The limitation of surgical masks are that they are not 
necessarily designed to seal tightly to the face, thus air 
can potentially leak around the edges. Hence, they do not 
completely reduce the exposure to airborne particles.35 
Respirators create an effective facial seal to cover the 
nose and mouth, aiding in preventing inhalation of hazar- 
dous airborne particles, gases and vapours. Respira- 
tors offer varying degrees of filtration, based on their 
classification.
Three key criteria  are required for  a  respirator to  be 
effective:36
1. The filter materials in the various layers used in the 
respirator needs to be extremely effective at captur- 
ing hazardous particles.
2. The respirator needs to fit snugly around the wearers 
face to create and maintain an effective facial seal. 
This seal minimises the amount of particles that are 
able to enter through gaps found between the skin 
and the respirator.
3. The respirator needs to be put-on (don) and removed 
(doff) correctly. 
Respirators have various descriptive criteria (letters) based 
on their resistance to oil. The letter in the name of the 
respirator rated as N, R or P.  This rating is important in 
industry because some industrial oils can degrade the 
filter performance so it does not filter properly for that 
environment. Respirators are rated ‘N’, if they are Not 
resistant to oil, ‘R’ if somewhat Resistant to oil, and ‘P’ 
if strongly  resistant  (oil Proof). 
The numerical value refers to the filtration capacity of 
the respirator. Therefore, a N95 respirator could also 
have ratings as R95 or P95 based on the industry 
with the same level of filtration to particles. In terms 
of the recommended N95, the European equivalent is 
FFP2 and for N99 it  is  FFP3.36
Additionally, some more expensive respirators will be 
approved by the National Institute for Occupational 
Safety and Health (NIOSH) in the United States to have 
the characteristics of both a respirator and a surgical 
mask (i.e. fluid-resistant to splash, splatter of blood and 
other bodily fluids) for use in theatres.
The N95 respirator provides 8-12 times more protection, 
than a surgical mask with exposure to particles with a 
size between 0.04-1.3 µm.37
National Institute for Occupational Safety and Health 
have produced valuable videos regarding PPE that can 
be viewed at the following online addresses: 
https://www.cdc.gov/niosh/docs/video/default.html
Respirators are certified through the Centre of Disease 
Control (CDC) and the National Institute for Occupa- 
tional Safety and Health (NIOSH) in the United States. 
All respirators in the United States need to comply with 
a complete respiratory program in accordance with the 
Occupational Safety and Health Administration (OSHA).36 
Each country has a performance standards to which the 
respirators must be produced. In South Africa, the per- 
formance standard is approved by the South African 
Bureau of Standards (SABS) and the National Regulator 
for Compulsory Specifications (NRCS) under SANS 103 
38: 2009. This is the equivalent performance standard 
from Europe EN149: 2001.
The Respiratory Protection Standards require all health 
care professionals to use respirators with tight fitting 
face pieces. Health care professionals also need to 
be adequately trained in the proper use, safe doffing 
and disposal of these respirators and can view various 
videos to educate  them on donning and doffing:
https://www.cdc.gov/niosh/npptl/topics/respirators/disp 
_part/donningdoffing.html.
Health care professionals also need to be knowledgeable 
on the medical conditions that provide contraindications 
of using respirators.36 Heart conditions, lung disease 
and psychological conditions like claustrophobia could 
be contra-indications to those clinicians. In the United 
States, OSHA recommend the evaluation of the staff 
member by a medical practitioner with a medical ques- 
tionnaire to evaluate the medical history and safety of 
the intended respirator for that practitioner. The question- 
naire can be obtained at this link:
https://www.osha.gov/laws-regs/regulations/standard 
number/1910/1910.134AppC.
Furthermore, it is a requirement from OSHA that all 
healthcare workers are expected to perform all activi- 
ties with suspected or confirmed cases of COVID-19 
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MANUFACTURE REGULATIONS  
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Figure 2. An example of a mask and respirator.33
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wearing respiratory protection. A filtering face piece such 
as a N95 respirator is recommended as it seals the 
face covering the mouth and nose. It also has the ability 
to remove 95% of airborne particles from the users 
breathing  air  due  to the built  in  filter.36
The CE marking and the performance standard of the 
respirator must be visible on the respirator, as well as on 
the packaging. Table 2 presents detail of the standard 
of testing, based on the various geographical locations 
where the respirators  were manufactured.
The Food and Drug administration in the Unites States 
released Table 2 on 28 March 2020 of allowed respira- 
tors against the COVID-19 pandemic for importation to 
the United States.
An adequately fitted respirator is of utmost importance 
to ensure there is no leakage around the edges of the 
respirator. The respirator needs to seal tightly and com- 
pletely on the wearer’s face. It is important to follow the 
user instructions and follow a user seal check before 
entering a contaminated or sterile environment.35
The seal of the respirator should be evaluated by feeling 
for exhaled air moving past the edges of the respirator. 
Any area where the seal is inadequate should be inves- 
tigated for facial hair and materials/cloth that may inter- 
fere with the respirator making contact with the skin. 
If the wearer is unable to shave then a Powered Air 
Purifying Respirator (PAPR) should be considered as an 
alternative. Some PAPR’s are designed to fit under the 
wearers chin or at the neck making them a suitable 
alternative.35 
1. Ensure adequate hand hygiene or first layer of cloves.
2. Hold the respirator in the palm of your hand with the 
straps facing the floor.
3. Place the respirator on your face covering your nose 
and mouth.
4. Pull the bottom strap up and over top of your head, 
and put it behind your head below your ears.
5. Take the upper strap and put it behind your head 
towards the crown of your head.
6. Mould the nosepiece of the respirator over the bridge 
of your nose to obtain a tight seal.
7. Perform a fit check to ensure there is a good seal 
against the skin.
The video illustrating this procedure is available at: 
https://www.cdc.gov/vhf/ebola/hcp/ppe-training/n95res- 
pirator_gown/donning_09.html
The main purpose of a respirator valve is to decrease 
breathing resistance during exhalation.  This has no impact 
on the respirators ability to provide adequate respira- 
tory protection to the OHCW. The design of the valves 
allows exhaled air to exit during exhalation and to tightly 
close during inhalation, consequently preventing any in- 
haled air  from entering the  valve  during inhalation. 
Due to the nature of the valve - it should not be re- 
commended to OHCW, since exhaled particles exiting 
the respirator through the valve will contaminate the 
environment or sterile field in theatre. Thus, they are 
not recommended for OHCW, as they could become 
the nexus for  local transmission.
In theory, the respirator can provide eight hours of res- 
piratory filtration. The largest risk of cross-contamination 
from the respirator to the OHCW is during doffing of the 
respirator and then self-inoculation from surface droplets. 
Wearing an ear loop mask or face shield, over the res- 
pirator could protect the respirator from surface con- 
tamination. The only truly viable option to reduce the daily 
numbers of respirators is to don the respirator and keep 
it on for the duration of the clinical day, with ear loop 
mask replacement after every patient.
In this time of COVID-19 with a worldwide shortage 
of PPE, the extended use of respirators is frequent. 
A respirator manufacturer has conducted research on 
the sterilisation procedures for respirators and assessed 
their subsequent filtration capacity. The four main crite- 
ria for successful disinfection investigated included the 
following: 
1). Be effective against the target organism (COVID-19). 
2). Not damage the respirator’s filtration.
3). Not affect the respirator’s fit.
4). Be safe for the person wearing the respirator (e.g. no 
off-gassing of chemicals into the breathing zone). 
FACIAL FIT AND SEAL TESTING
DONNING A PPE RESPIRATOR38
RESPIRATORS WITH VALVES
RE-USE OF RESPIRATORS
Table 2. COVID-19 respirators imported to United States.
Jurisdiction Made to performance standard Acceptable product classifications Standards / Guidance documents
Australia AS/NZS 1716:2012 P3, P2 AS/NZS 1715:2009
Brazil ABNT/NBR 13698:2011 PFF3, PFF2 Fundacentro CDU 614.894
Europe EN 149-2001 FFP3, FFP2 EN 529:2005
Japan JMHLW-2000 DS/DL3, DS/DL2 JIS T8150: 2006
Korea KMOEL-2017-64 Special 1st KOSHA GUIDE H-82-2015
USA / Canada NIOSH / FDA Health Canada Licence N95 surgical respirator NIOSH approved
Mexico NOM-116-2009 N100, P100, R100, N99, P99, R99, N95, P95, R95 NOM-116
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3). Ultraviolet germicidal irradiation (UVGI).
4). Microwave-generated stream (MGS).
5). Moist heat. 
These disinfection methods did not completely meet 
the set out criteria, to be justified as successful. As of 
27 March 2020, no disinfection method has met all 
four of these key criteria, and without all four, the 
method is not acceptable. 3M is now working with 
several major sterilization and disinfection companies 
and consulting with external experts to develop an 
effective disinfection method. 3M is working towards 
a solution to meet the abovementioned criteria.39 
The CDC therefore have stated discarding recommen- 
dations for respirators, to prevent a significant risk for 
contact transmission, self-inoculation or reduced func- 
tionality 40:
1). Discard respirators following use during aerosol ge- 
nerating procedures.
2). Discard respirators contaminated with blood, res- 
piratory or nasal secretions, or other bodily fluids 
from patients.
3). Discard respirators following close contact with any 
patient co-infected with an infectious disease requiring 
contact precautions in Table 2.
4). Consider the use of a cleansable face shield41 over a 
respirator and/or other steps (e.g. masking patients, 
use of engineering controls), when feasible to reduce 
surface contamination of the respirator.
5). Hang used non-contaminated respirators in a desig- 
nated storage area or keep them in a clean, breathable 
container such as a paper bag between uses.
6). To minimize potential cross-contamination, store res- 
pirators so that they do not touch each other and the 
person using  the respirator is clearly  identified.
7). Storage containers should be disposed of or clean- 
ed regularly.
8). Clean hands with soap and water or an alcohol- 
based hand sanitizer before and after touching or 
adjusting the respirator (if necessary for comfort or 
to maintain fit).
9). Avoid touching the inside of the respirator. If in- 
advertent contact occurs with the inside of the 
respirator, discard the respirator and perform hand 
hygiene  as described above.
10). Use a pair of clean (non-sterile) gloves when donning 
a used respirator and performing a user seal check. 
Discard gloves after the respirator is donned and after 
any adjustments are made to ensure the respirator is 
creating an effective facial seal.
The WHO and CDC have published a table of recom- 
mendations to curb the spread of COVID-19 in health 
care facilities. This table is continuously in flux and up- 
dates are available on the websites of the CDC and 
WHO, as the COVID-19 pandemic is further studied and 
knowledge increases.
During daily dental procedures, aerosol production is 
often unavoidable. Due to the nature of the dental 
setting and current findings in the literature, it is the 
opinion of the authors that only N95/FFP 2 (or equivalent 
respirators) are recommended for OHCW during this 
COVID-19 pandemic. 
OHCW additionally should take the steps outlined to 
minimise aerosol production and adhere to the current 
recommendations of disinfection protocols as set out by 
the CDC.
The authors declare no conflict of interest.




Table 3. Transmission-based precautions and specific infection pre- 





Standard To minimise the spread of in-
fection within healthcare fa-





Environmental cleaning  
and disinfection
Proper handling of patient 
care equipment and waste 
management
Proper handling of needles and 
other sharps
Contact To minimise the spread of in-
fections particularly by hand-
to-hand contact and self-in-
oculation of nasal and/or 
conjunctival mucosa
Proper use of PPE including 
disposable gloves and gowns
Appropriate patient placement 
in a single room or with patient 
infected by some pathogen
Limit patient movement and mi-
nimise patient contact
Environmental cleaning and 
disinfection of the patient room
Droplet To minimise the spread of re-
spiratory infections that are 
transmitted predominantly via 
large droplets (>5µm) in short 
distance
Proper use of PPE including 
surgical mask when entering 
the patient’s room
Appropriate patient placement 
in a single room or with patient 
infected by same pathogen.
Limit patient movement and 
ensure that patients wear sur-
gical mask when outside their 
rooms.
Airborne To minimise the spread of 
respiratory infections that are 
transmitted through inhalation 
of infectious aerosols (≤5µm) 
over a long distance
Proper use of PPE including 
N95/FFP2 or equivalent partic-
ulate respirator.
Isolation of patient in single, 
airborne isolation infection 
room (AIIR).
Limit patient movement and en-
sure that patients wear surgical 
mask when outside their rooms.
Contact, droplet and airborne precautions are considered as transmission-based 
precautions that should be implemented in addition to standard precautions.
REVIEW180 >
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Table 4. Technical details on masks and respirators
Category Cloth masks Surgical masks N95 (3M)
Model 1860S Model 1870+ VFlex
Can be used as 
 a medical device 
No Yes Yes Yes Yes
Filter efficiency Currently no published 
research available on 
efficacy of cloth masks.
Does not provide the wearer 
with a protection from inhala-
tion of small airborne particles. 
Not considered respiratory pro-
tection.
≥95% of airborne particles 
(Both large and small).
≥95% of airborne particles 
(Both large and small).
≥95% of airborne particles 
(Both large and small).
Purpose Used to block large particles/
droplets that may contain 
micro-organisms. 
Protects the patient from the 
wearer’s respiratory emissions.
Reduces the wearers 
exposure to large droplets/
particles and smaller 
particle aerosols.
Reduces the wearers ex-
posure to large droplets/
particles and smaller par-
ticle aerosols.
Reduces the wearers 
exposure to large droplets/
particles and smaller 
particle aerosols.
Face seal fit Loose/ill-fitting. Loose fitting. Tight fitting, seals over 
mouth and nose
Tight fitting, seals over 
mouth and nose.
Tight fitting, seals over 
mouth and nose.
User seal check 
requirement
No. No. Yes – required every time 
its put on.
Yes – required every time 
its put on.
Yes – required every time 
its put on.
Leakage Leakage can occur 
through the fabric and 
around the edges of  
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Leakage occurs around the 
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face and mask.
When correctly put on and 
fitted - minimal leakage 
occurs.
When correctly put on and 
fitted - minimal leakage 
occurs.
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fitted - minimal leakage 
occurs.
Fluid resistance Not fluid resistant 0.04µm-1.3 µm Splashes at 120mm Hg.
Not resistant to oil
Splashes at 160 mm Hg.
Not resistant to oil.
Splashes at 80mm Hg.
Not resistant to oil.
Valve/no valve No No No valve No valve No valve
Use limitation Non-surgical/medical.
Needs to be washed 
frequently. 
Disposable. 
Discard after each patient en-
counter. 
Should ideally be discar- 
ded after each patient or 
after an aerosol producing 
procedure. 
Discarded if damaged or 
deformed or the seal is 
defective.
Should be discarded if 
it becomes contaminated 
with blood or other bodily 
fluids from patients.
Should ideally be discar- 
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Filter efficiency ≥99% of airborne particles 
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≥94% of airborne particles 
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≥99% of airborne particles 
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large droplets/particles and smaller 
particle aerosols.
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large droplets/particles and smaller 
particle aerosols.
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large droplets/particles and smaller 
particle aerosols.
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and nose.
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bodily fluids from patients.
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